Impact Investing Scope Global Health Investment Corporation is an impact investment firm with a track record of funding and scaling health innovations in low- and middle-income markets, presenting opportunities to cross-sell portfolio company solutions to GHIC's network and to align on mission-driven procurement.

Global Health Security GHIC has formal involvement in global health security and pandemic preparedness through BARDA partnerships and a dedicated fund, signaling openness to collaborations around rapid diagnostics, vaccines, therapeutics, and preparedness technologies for both public and private sector buyers.

Recent Portfolio Activity Active investments in Centivax, Antheia, and Aerska indicate a focus on RNA delivery, biomanufacturing, and advanced therapeutics, suggesting sales opportunities for enabling technologies, manufacturing scale, regulatory support, and distribution channels to global health players.

Funding Capability GHIC’s demonstrated ability to mobilize substantial capital (Series A to late-stage rounds, 100M financing milestones) positions it as a potential co-investor or anchor client for vendors offering scalable clinical and manufacturing platforms, contract services, or risk-sharing financial instruments.

Partnership Potential Strategic collaborations with government-like entities and private partners (BARDA, public-private initiatives, and health security funds) create doors for pilots, pilot-to-scale programs, and joint ventures in global health delivery, delivery systems strengthening, and emergency response technology adoption.